Literature DB >> 9406260

Use of electroconvulsive therapy in the Medicare population between 1987 and 1992.

M L Rosenbach1, R C Hermann, R A Dorwart.   

Abstract

OBJECTIVE: Use of electroconvulsive therapy (ECT) in the Medicare population was examined to document trends and variations in the rate of use, expenditures, and patterns of treatment.
METHODS: Medicare part B enrollment and claims data were used for a 5 percent nationally representative sample of Medicare beneficiaries for calendar years 1987 through 1992. Descriptive and multivariate analyses were performed.
RESULTS: Weighted results showed that nationally the number of Medicare beneficiaries treated with ECT increased from 12,000 in 1987 to 15,560 in 1992. The rate of ECT use per 10,000 Medicare beneficiaries also increased from 4.2 to 5.1. Increases in use occurred among women, whites, and the disabled population (under age 65). Males, nonwhites, and the elderly did not share in the increase. Utilization and expenditure data showed an increase in outpatient ECT and a decrease in inpatient use between 1987 and 1992. The share of Medicare part B ECT expenditures in the outpatient setting increased steadily, from 7 percent in 1987 to 16 percent in 1992. Patients averaged eight ECT treatments, ranging from 6.7 in the West to 8.3 in the Northeast.
CONCLUSIONS: The findings document that after a long period of declining use in the United States, ECT use in the Medicare population increased between 1987 and 1992. The analysis also documents a shift toward increasing use of outpatient ECT.

Entities:  

Mesh:

Year:  1997        PMID: 9406260     DOI: 10.1176/ps.48.12.1537

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  8 in total

1.  Declining use of electroconvulsive therapy in United States general hospitals.

Authors:  Brady G Case; David N Bertollo; Eugene M Laska; Lawrence H Price; Carole E Siegel; Mark Olfson; Steven C Marcus
Journal:  Biol Psychiatry       Date:  2012-10-08       Impact factor: 13.382

2.  Contemporary use and practice of electroconvulsive therapy worldwide.

Authors:  Kari Ann Leiknes; Lindy Jarosh-von Schweder; Bjørg Høie
Journal:  Brain Behav       Date:  2012-05       Impact factor: 2.708

Review 3.  Interactions between psychotropics, anaesthetics and electroconvulsive therapy: implications for drug choice and patient management.

Authors:  Mohamed Naguib; Robert Koorn
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

4.  Current electroconvulsive therapy practice and research in the geriatric population.

Authors:  Nancy Kerner; Joan Prudic
Journal:  Neuropsychiatry (London)       Date:  2014-02

Review 5.  Electroconvulsive therapy in the medically ill.

Authors:  Eric J Christopher
Journal:  Curr Psychiatry Rep       Date:  2003-07       Impact factor: 5.285

6.  Monitoring daily affective symptoms and memory function using interactive voice response in outpatients receiving electroconvulsive therapy.

Authors:  Tera L Fazzino; Terry Rabinowitz; Robert R Althoff; John E Helzer
Journal:  J ECT       Date:  2013-12       Impact factor: 3.635

7.  Current clinical practice of electroconvulsive therapy and repetitive transcranial magnetic stimulation in psychiatry, a German sample.

Authors:  Charles Timäus; Jonathan Vogelgsang; Bernhard Kis; Katrin Radenbach; Claus Wolff-Menzler; Kiriaki Mavridou; Stephan Gyßer; Philipp Hessmann; Jens Wiltfang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-01-29       Impact factor: 5.270

8.  Inpatient Psychiatric Care of Medicare Beneficiaries With State Buy-In Coverage.

Authors:  Susan L Ettner
Journal:  Health Care Financ Rev       Date:  1998
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.